Biotechnology's new wave in Florida by unknown
Marine biotechnology is a new economic sector
globally, and is in its infancy in Florida. As an industry, it
is still a very small part of biotechnology overall, but one
where Florida has potential and real advantages over
many areas for developing a robust commercial,
technical and educational investment.
Issues and opportunities
for developing ideas, products and
services from the ocean
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Florida’s coasts and ocean
systems are major components of
the state’s economy. Beach
tourism, fishing and boating are
all economic powerhouses. Can
‘marine biotechnology’ attain
such stature?
F
lorida Sea Grant conducted a project to describe
the awareness, interest and effort of a cross-
section of Florida’s biotechnology industry. Its aim
was to characterize Florida business, including
research and entrepreneurial interests in opportunities
related to the resources of the ocean and its outlook to
develop ocean-related products and processes. This study
attempted to take the pulse of Florida’s biotechnology
industry in order to inform business leaders, university
faculty, and government/legislative interests about possi-
bilities for development of this sector.
Forty of the “core” organizational members of
BIOFlorida (the industry’s statewide trade association) were
contacted and invited to participate. With guidance from
the state’s economic development agency, Enterprise
Florida, questions were posed to determine each
organization’s effort in biotechnology overall, current or
planned activity related to ocean resources, and level of
interest in learning more about the field.
findings, patents and ideas ready for com-
mercialization. Florida Sea Grant provides a
directory (TP 110) describing the research of
76 faculty at major universities and marine
research centers throughout the state (see
web sites on final page).
These assets, coupled with state and local
economic development initiatives, can only
help propel Florida’s ocean biotechnology
efforts. Enterprise Florida plans to spend at
least $1 million on a marketing plan directed
toward executives in the pharmaceutical and
biotechnology industries, to encourage high
tech companies to move to Florida, bringing
knowledge-based jobs to the Sunshine State.
Florida’s position among states that are
national leaders in marine biotechnology has
already been promoted through the
partnering to date of state agencies, univer-
sity and marine laboratory research, and the
fledgling industry itself. What is needed is
long-term funding for research, education
and development, to capitalize on these
existing partnerships.
The benefits from marine biotechnology
will be many, including economic diversifica-
tion, the creation of clean industry and high-
paying jobs, and retention of well-trained
students and expert scientists in Florida.
More importantly, the development of
products and services through marine
biotechnology promises to improve the
quality of our lives and the environment in
which we live.
Mike Kane at the University
of Florida has led
research to develop a
commercially viable tech-
nique for cloning sea oats.
This superior sea oat is now
widely used in coastal
dune restoration efforts
throughout Florida.
Researchers such as Shirley
Pomponi of Harbor Branch
Oceanographic Institution
continue to develop
bioactive compounds and
pharmacological agents
from organisms found
naturally in the sea.
Florida biotechnology companies emphasize three principal activities:
production/manufacturing; research; and, business development/
services.
Good News, Bio-News
The good news is that there were 22 respondents out
of the study sample of 40. Statistically, that represents a
55 percent return, and the study findings based on
these responses provide a credible indicator of these
respondents’ position in the industry. The bio-news is
that, without the cooperation of the other 18 firms that
were contacted, it is not possible to project study find-
ings in a way that can be fully representative of the state
marine biotechnology industry. On the upside, despite
this study limitation, important information can be
summarized and generalized with confidence about the
marine biotechnology industry in Florida.
Enhancing the
Marine
Biotechnology
Climate
The relatively low level of
ocean-related effort in Florida’s
biotechnology industry is not
surprising in view of the state’s
limited overall biotechnology
effort (Florida ranks 10th nation-
wide in number of firms). But, it
is surprising considering the
state’s extensive resources,
natural and human. Currently,
out-of-state firms not only hire
Florida students away, but also
sponsor and use research by
Florida marine laboratories and
university scientists.
For Florida’s “New Wave” of biotechnology — specifically, marine
biotechnology — to advance, it will have to capitalize on its advantages
nationally. First, the state’s natural environment is a huge resource be-
cause the high diversity of bays and oceans provides a storehouse of
potential pharmaceutical, industrial and environmental products. A big
plus: the only coral reef tracts in the mainland U.S. lie in the Florida Keys.
From sponges, algae, coral and other organisms, research has already
derived a popular cosmetic ingredient and techniques for “fingerprinting”
marine products.
Second, a statewide consortium of university scientists is already
tackling a range of issues including biomedical effectiveness of marine
compounds, biosensors for detection of contaminants in marine waters
and food products, and genetics. The effort is yielding not only trained
students ready to work in industry, but also basic and applied technical
A statewide consortium of university
researchers is advancing Florida’s marine
biotechnolgical research and education.
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Many biotechnology companies in
Florida are small.
While 22 of them provided information for this
study, in several other cases limited staff simply
could not respond due to competing office needs
and out-of-office workload.
Most Florida companies focus on
medical aspects of
biotechnology.
None of the firms or businesses reported that they
address industrial compounds, quality of products
or environment, or aquaculture.
Florida biotechnology companies
emphasize three principal
activities.
Findings
Ocean-related biotechnology is at a low
level in Florida.
Five of the 22 businesses indicate involvement with aquatic
and marine subjects, including two that focus on medical
aspects of plant and fish physiological processes.
More than one third of respondents (8)
expressed interest in an executive educa-
tion course on marine biotechnology is-
sues.
The response represents 36 percent of the sample indicating
interest in opportunities and practices that would enable
informed decisions about level of involvement in the field.
Florida’s small biotechnology sector may be poised to expand opportunities to develop medicines,
industrial products and diagnostic procedures from the state’s bountiful ocean systems.
There is equal emphasis among the three activities,
namely production/manufacturing; research; and
business development/services.
A majority of Florida biotechnology firms
providing information expressed some
level of interest in the potential of marine
biotechnology.
None of the five firms currently active in the field dismissed future
activity. Of the 17 respondents not currently involved, more than
half (9) indicated some interest in the field’s potential.
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